ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2998

Gut Microbiota Induce IGF-1 and Promote Bone Formation and Growth

Jing Yan1, Jeremy Herzog2, Kelly Tsang1, R. Balfour Sartor2, Antonios Aliprantis3 and Julia F. Charles1, 1Medicine/Rheumatology, Brigham and Women's Hospital, Boston, MA, 2National Gnotobiotic Rodent Resource Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Rheumatology, Allergy and Immunology, Brigham and Women's Hospital, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Bone, insulin-like growth factor and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Biology and Pathology of Bone and Joint

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Appreciation of the role of the gut microbiome in regulating vertebrate metabolism has exploded recently. However, the effects of gut microbiota on skeletal growth and homeostasis have only recently been explored.

Methods: To understand the effects of short-term and long-term colonization of microbiota on bone, we colonized sexually mature germ-free (GF) mice with gut microbiota from SPF mice. In complementary experiments, SPF mice were treated with antibiotics to deplete microbiota. Bone parameters were examined by micro-computed tomography (micro-CT) and histomorphometry 1 month after colonization. Micro-CT analysis was also performed 8 months after colonization. Serum C-terminal telopeptide (CTX), amino-terminal propeptide (P1NP) and insulin like growth factor 1 (IGF-1) were measured by ELISA.

Results: Reduced bone mass was observed one month after colonization, reflecting increases in bone resorption as measured by CTX. However, bone formation was significantly increased. Increased bone formation was demonstrated by both elevated bone formation rate measured by dynamic histomorphometry and increases in serum P1NP, a marker of bone formation. In addition, short-term colonized mice displayed a widen growth plate, suggesting that microbiota promotes longitudinal bone growth. In mice colonized for 8 months, increased bone formation and growth plate activity predominate, resulting in equalization of bone mass and increased longitudinal and radial bone growth. Serum levels of IGF-1, a hormone with known actions on skeletal growth, were substantially increased in response to colonization, with significant increases in liver and adipose tissue IGF-1 production. Antibiotic treatment of conventional mice, in contrast, decreased serum IGF-1 and inhibited bone formation, suggesting that skeletal effects of microbiota are mediated by IGF-1. Treatment with vancomycin, a non-absorbable antibiotic that only targets gram positive bacteria, was sufficient to decrease serum IGF-1 and inhibit bone formation, indicating that gram positive commensals are sufficient for the regulation of bone formation by microbiota.

Conclusion: Colonization increases both bone formation and resorption, with the net effect of colonization varying with the duration of colonization. Long-term colonization with microbiota provides a net anabolic stimulus to the skeleton, which is likely regulated by IGF-1. Manipulation of the microbiome may afford opportunities to optimize bone health and growth.


Disclosure: J. Yan, None; J. Herzog, None; K. Tsang, None; R. B. Sartor, None; A. Aliprantis, None; J. F. Charles, None.

To cite this abstract in AMA style:

Yan J, Herzog J, Tsang K, Sartor RB, Aliprantis A, Charles JF. Gut Microbiota Induce IGF-1 and Promote Bone Formation and Growth [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/gut-microbiota-induce-igf-1-and-promote-bone-formation-and-growth/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbiota-induce-igf-1-and-promote-bone-formation-and-growth/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology